vs

Side-by-side financial comparison of FB Financial Corp (FBK) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

FB Financial Corp is the larger business by last-quarter revenue ($178.6M vs $37.2M, roughly 4.8× Organogenesis Holdings Inc.). On growth, FB Financial Corp posted the faster year-over-year revenue change (37.0% vs -57.1%). Over the past eight quarters, FB Financial Corp's revenue compounded faster (28.9% CAGR vs -46.5%).

Fubon Financial Holding Co., Ltd. is a financial investment holding company consists of the following key subsidiaries: Fubon Asset Management, Fubon Insurance Co. Ltd., Fubon Securities, Fubon Bank, Fubon Life, Fubon Bank (China) and Fubon Bank Limited. The holding company was setup on 19 December 2001.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

FBK vs ORGO — Head-to-Head

Bigger by revenue
FBK
FBK
4.8× larger
FBK
$178.6M
$37.2M
ORGO
Growing faster (revenue YoY)
FBK
FBK
+94.0% gap
FBK
37.0%
-57.1%
ORGO
Faster 2-yr revenue CAGR
FBK
FBK
Annualised
FBK
28.9%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
FBK
FBK
ORGO
ORGO
Revenue
$178.6M
$37.2M
Net Profit
$57.0M
Gross Margin
30.8%
Operating Margin
39.1%
-185.1%
Net Margin
31.9%
Revenue YoY
37.0%
-57.1%
Net Profit YoY
50.4%
EPS (diluted)
$1.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FBK
FBK
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$178.6M
$225.6M
Q3 25
$173.9M
$150.9M
Q2 25
$76.9M
$101.0M
Q1 25
$130.7M
$86.7M
Q4 24
$130.4M
$126.7M
Q3 24
$89.5M
$115.2M
Q2 24
$128.2M
$130.2M
Net Profit
FBK
FBK
ORGO
ORGO
Q1 26
Q4 25
$57.0M
$43.7M
Q3 25
$23.4M
$21.6M
Q2 25
$2.9M
$-9.4M
Q1 25
$39.4M
$-18.8M
Q4 24
$37.9M
$7.7M
Q3 24
$10.2M
$12.3M
Q2 24
$40.0M
$-17.0M
Gross Margin
FBK
FBK
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
FBK
FBK
ORGO
ORGO
Q1 26
-185.1%
Q4 25
39.1%
28.1%
Q3 25
17.0%
13.7%
Q2 25
-12.7%
-12.5%
Q1 25
37.4%
-30.9%
Q4 24
38.4%
8.1%
Q3 24
12.7%
5.4%
Q2 24
39.7%
-10.7%
Net Margin
FBK
FBK
ORGO
ORGO
Q1 26
Q4 25
31.9%
19.4%
Q3 25
13.4%
14.3%
Q2 25
3.8%
-9.3%
Q1 25
30.1%
-21.7%
Q4 24
29.1%
6.1%
Q3 24
11.4%
10.7%
Q2 24
31.2%
-13.1%
EPS (diluted)
FBK
FBK
ORGO
ORGO
Q1 26
Q4 25
$1.12
$0.31
Q3 25
$0.43
$0.11
Q2 25
$0.06
$-0.10
Q1 25
$0.84
$-0.17
Q4 24
$0.82
$0.05
Q3 24
$0.22
$0.09
Q2 24
$0.85
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FBK
FBK
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$1.2B
$91.4M
Total DebtLower is stronger
$212.8M
Stockholders' EquityBook value
$1.9B
Total Assets
$16.3B
$520.0M
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FBK
FBK
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$1.2B
$93.7M
Q3 25
$1.3B
$63.7M
Q2 25
$1.2B
$73.1M
Q1 25
$794.7M
$110.0M
Q4 24
$1.0B
$135.6M
Q3 24
$951.8M
$94.3M
Q2 24
$800.9M
$89.9M
Total Debt
FBK
FBK
ORGO
ORGO
Q1 26
Q4 25
$212.8M
Q3 25
$213.6M
Q2 25
Q1 25
Q4 24
$176.8M
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
FBK
FBK
ORGO
ORGO
Q1 26
Q4 25
$1.9B
$300.1M
Q3 25
$2.0B
$255.1M
Q2 25
$1.6B
$233.2M
Q1 25
$1.6B
$242.9M
Q4 24
$1.6B
$262.9M
Q3 24
$1.6B
$278.5M
Q2 24
$1.5B
$263.5M
Total Assets
FBK
FBK
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$16.3B
$598.7M
Q3 25
$16.2B
$509.8M
Q2 25
$13.4B
$461.1M
Q1 25
$13.1B
$467.4M
Q4 24
$13.2B
$497.9M
Q3 24
$12.9B
$446.3M
Q2 24
$12.5B
$443.2M
Debt / Equity
FBK
FBK
ORGO
ORGO
Q1 26
Q4 25
0.11×
Q3 25
0.11×
Q2 25
Q1 25
Q4 24
0.11×
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FBK
FBK
ORGO
ORGO
Operating Cash FlowLast quarter
$155.9M
Free Cash FlowOCF − Capex
$147.0M
FCF MarginFCF / Revenue
82.3%
Capex IntensityCapex / Revenue
5.0%
Cash ConversionOCF / Net Profit
2.74×
TTM Free Cash FlowTrailing 4 quarters
$242.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FBK
FBK
ORGO
ORGO
Q1 26
Q4 25
$155.9M
$39.4M
Q3 25
$47.7M
$3.1M
Q2 25
$71.8M
$-32.9M
Q1 25
$-16.5M
$-19.9M
Q4 24
$138.8M
$10.9M
Q3 24
$57.8M
$8.7M
Q2 24
$30.6M
$4.7M
Free Cash Flow
FBK
FBK
ORGO
ORGO
Q1 26
Q4 25
$147.0M
$34.8M
Q3 25
$45.6M
$844.0K
Q2 25
$68.4M
$-36.5M
Q1 25
$-18.1M
$-23.6M
Q4 24
$132.3M
$7.6M
Q3 24
$56.7M
$6.1M
Q2 24
$28.4M
$2.9M
FCF Margin
FBK
FBK
ORGO
ORGO
Q1 26
Q4 25
82.3%
15.4%
Q3 25
26.2%
0.6%
Q2 25
89.0%
-36.1%
Q1 25
-13.9%
-27.2%
Q4 24
101.4%
6.0%
Q3 24
63.3%
5.3%
Q2 24
22.1%
2.2%
Capex Intensity
FBK
FBK
ORGO
ORGO
Q1 26
Q4 25
5.0%
2.1%
Q3 25
1.2%
1.5%
Q2 25
4.4%
3.6%
Q1 25
1.3%
4.2%
Q4 24
5.0%
2.7%
Q3 24
1.2%
2.2%
Q2 24
1.7%
1.4%
Cash Conversion
FBK
FBK
ORGO
ORGO
Q1 26
Q4 25
2.74×
0.90×
Q3 25
2.04×
0.14×
Q2 25
24.68×
Q1 25
-0.42×
Q4 24
3.66×
1.43×
Q3 24
5.65×
0.71×
Q2 24
0.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons